SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-22-017370
Filing Date
2022-02-10
Accepted
2022-02-10 06:05:13
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-1 tm225911d1_s1.htm S-1 335611
2 EXHIBIT 23.1 tm225911d1_ex23-1.htm EX-23.1 2517
3 EX-FILING FEES tm225911d1_exfilingfees.htm EX-FILING FEES 24891
4 GRAPHIC tm225911d1_s1img001.jpg GRAPHIC 6920
  Complete submission text file 0001104659-22-017370.txt   373710
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-262614 | Film No.: 22609414
SIC: 2836 Biological Products, (No Diagnostic Substances)